Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 10, 2013, Pages 1341-1345

  Papanikolaou, E G ^a,c   Kyrou, D ^a   Zervakakou, G ^a   Paggou, Efstathia ^a   Humaidan, P ^b  

^a Human Reproduction and Genetics Foundation   (Greece)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Royal Hyatt Hospital   (Kuwait)

Author keywords

Estrogen replacement; Frozen cycles; HCG; Implantation; Poor prognosis; Thin endometrium

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; ENDOMETRIUM; ESTROGEN THERAPY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; PILOT STUDY; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADULT; CHORIONIC GONADOTROPIN; COHORT STUDIES; EMBRYO TRANSFER; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; OVARIAN FOLLICLE; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES;

EID: 84887989451     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0076-0     Document Type: Article

References (21)

1. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217-27.
2. Bourdiec A, Shao R, Rao CV, Akoum A. human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod. 2012;87:66.
3. Bourgain C, Devroey P. Histologic and functional aspects of the endometrium in the implantatory phase. Gynecol Obstet Invest. 2007;64:131-3.
4. Check JH, Graziano V, Lee G, Nazari A, Choe JK, Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clin Exp Obstet Gynecol. 2004;31:99-102.
5. Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23:337-4.
6. Cicek N, Eryilmaz OG, Sarikaya E, Gulerman C, Genc Y. Vitamin E effect on controlled ovarian stimulation of unexplained infertile women. J Assist Reprod Genet. 2012;29:325-8.
7. Detti L, Yelian FD, Kruger ML, Diamond MP, Puscheck EE. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles. J Ultrasound Med. 2008;27:1591-6.
8. Dix E, Check JH. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Clin Exp Obstet Gynecol. 2010;37:15-6.
9. Elizur SE, Son WY, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in-vitro maturation cycles with thin endometrial lining. Fertil Steril. 2009;92:907-12.
10. Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update. 2007;13:581-90.
11. Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95:2123.
12. Licht P, Russu V, Lehmeyer S, Wildt L. Molecular aspects of direct LH/hCG effects on human endometrium-lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol. 2001;1:10-9.
13. Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003;79 Suppl 1:718-23.
14. Prapas N, Tavaniotou A, Panagiotidis Y, Prapa S, Kasapi E, Goudakou M, et al. Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients. Gynecol Endocrinol. 2009;25:53-9.
15. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70:421-30.
16. Saha TK, Amer SA, Biss J, Thakare H, Williams S, Farrell CT, et al. The validity of transvaginal ultrasound measurement of endometrial thickness: a comparison of ultrasound measurement with direct anatomical measurement. BJOG. 2004;111:1419-24.
17. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol. 2008;20:221-8.
18. Sher G, Herbert C, Maassarani G, Jacobs MH. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod. 1991;6:232-7.
19. Shufaro Y, Simon A, Fatum M. Thin unresponsive endometrium - a possible complication of surgical curettage compromising ART outcome. J Assist Reprod Genet. 2008;25:421-5.
20. Zenke U, Chetkowski RJ. Transfer and uterine factors are the major recipient-related determinants of success with donor eggs. Fertil Steril. 2004;82:850.
21. Zhu W, Chen M, Liu J, Fu Z, Li X, Qin C, et al. Receptivity assessment of an ultrasonographic homogeneous endometrium in the late follicular phase of infertile women with natural cycles. Am J Obstet Gynecol. 2012;207:511-7.